ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Business Reporter: affordable cancer care will be instrumental to eliminating avoidable deaths globally

How state-of-the art health technology can help bring the achievement of a Sustainable Development Goal (SDG) closer

LONDON, UNITED KINGDOM, July 2, 2021 /EINPresswire.com/ -- In a video published by Business Reporter, Gustaf Salford, CEO of Stockholm-based Elekta, a medical device company that manufactures radiotherapy solutions for cancer care, talks with the company’s leaders about brachytherapy, a form of radiation therapy that can save women’s lives and shorten cervical cancer treatment times. If deployed in developing countries, brachytherapy can play a key role in delivering the UN’s goal to reduce mortality from cancer and other non-communicable diseases by a third by 2030.

Every year more than half a million women are diagnosed with cervical cancer around the world, 85 per cent of them in low- and middle-income countries. Combined with efficient diagnostics, increasing the availability of the best cervical cancer treatments in these regions can lead to significantly lower mortality among women, as well as fewer and shorter periods of disruption to patients’ lives thanks to more targeted treatments.

Cutting-edge medical equipment, however, needs to be operated by well-trained doctors and staff to reach its full potential. To this end, Elekta offers educational opportunities that combine online training with face-to-face instruction, and a collaborative platform with peer-to-peer training.

In addition to the medical benefits of treating GYN cancers with brachytherapy, Umesh Mahantshetty MD, Director and Radiation Oncologist at Homi Bhabha Hospital in Visakhapatnam, India, also talks about the economics of investing in the treatment technique in the video. Adding brachytherapy to the radiotherapy service requires a low upfront capital investment, he explains, therefore cash-strapped medical departments can also afford it. Moreover, governments investing in it will also see a quick return, as women who undergo the therapy stand a much better chance of swiftly returning to both their work and family lives.

To learn more about how brachytherapy works, as well as its social and economic benefits, watch the video.

•• About Business Reporter ••

Business Reporter is an award-winning supplement published with The Economist and online, delivering news and analysis on issues affecting businesses to a global audience. It also hosts conferences, debates, breakfast meetings and exclusive summits.
www.business-reporter.co.uk

•• About Elekta ••

Elekta is a Swedish company that provides radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders. Its brachytherapy solutions, developed and produced in the Netherlands, are shipped to 40 countries.

https://www.elekta.com/

Business Reporter
Press
+44 20 8349 4363
email us here

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.